Biotechnology

Immunodiagnostics Market Increasing Prevalence of Infectious Diseases

Immunodiagnostics is referred as a diagnostic methodology that primarily uses antigen-antibody reaction as its primary means of detection. Antibodies specific for a desired antigen can be conjugated with a radiolabel, fluorescent label, or color-forming enzyme and are used as a probe to detect it. The speed, accuracy and simplicity of such tests has led to the development of rapid techniques for the diagnosis of disease, microbes and even illegal drugs in vivo.

The immunodiagnostic market is expected to reach US$ 29,526.72 million by 2028; registering at a CAGR of 7.4% from 2022 to 2028, according to a new research study conducted by The Insight Partners.

The scope of the immunodiagnostics market includes product, clinical indication, end user, and region.

The membrane separation systems market is majorly comprised of top players involving Abbott Laboratories, F. Hoffmann-La Roche Ltd, DiaSorin SpA, Danaher Corp, Thermo Fisher Scientific Inc, PerkinElmer Inc, Shenzhen Mindray Bio-Medical Electronics Co Ltd, bioMerieux SA, Svar Life Science AB, and Siemens Healthineers AG.

The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.

Below is the list of the growth strategies done by the players operating in the immunodiagnostics market:

Year News
July-2022 Abbott Diagnostics announced its participation in American Association for Clinical Chemistry (AACC) 2022. in the exhibition, the company has demonstrated its diagnostics systems and analyzers.
May-2022 Roche and The Global Fund to Fight AIDS, Tuberculosis and Malaria joined forces to build and strengthen diagnostic capacity and pandemic preparedness in low-and middle-income countries fighting against HIV and tuberculosis (TB).
Sep-2022 Mindray launched the ToRCH Panel. With this panel, the company offers high-quality assays to meet different clinical needs. Mindray ToRCH kits support diverse sample types with less quality controls and sample volumes, which ensures great ease and convenience during clinical detection.